Dow Agrosciences LLC

Corteva Agriscience LLC

Janna Mai Armstrong

Krishna M Madduri

Audrey Jane Etter

Kenneth Edwin Narva

Sek Yee Tan

Joel Jay Sheets

Premchand Gandra

Gaofeng Lin

Ted Letherer

Donald J Merlo

Steven Robert Webb

Timothy Denver Hey

William M Ainley

Meghan Frey

Kelley Ann Smith

Mark Allen Thompson

Liu Shen

Haley Mowery

Thomas Meade

Rainer Fischer

Todd P Glancy

James Edward King

Stefan Schillberg

Ryan M Lee

Simon Vogel

Jianquan Li

Tristan E Coram

Matthias Buntru

Meghan L F Frey

Xiaoping Xu

Haley Ellis

James E King

Kenneth Narva

Joel J Sheets

Timothy D Hey

DIG-657 vegetative insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed. The invention includes DIG-657 variants, fragments and analogs.

Vegetative insecticidal proteins useful for control of insect pests

Insecticidal toxins derived from, polynucleotides encoding such toxins, use of such toxins to control plant pests, and transgenic plants that produce, and are protected, by these toxins are described.

IRDIG17912 insecticidal Cry toxins

This disclosure concerns the systems, methods, and kits for the in vitro synthesis of biological macromolecules in a reaction utilizing cell lysates containing plastids, mitochondria and/or chloroplasts, wherein creatine phosphate and creatine kinase are not added to the reaction to provide artificial energy regeneration.

Eukaryotic cell-free protein expression system that does not require an artificial energy regeneration system

The subject invention concernsmodified Cry1Ca insecticidal toxins and the polynucleotide sequences which encode these toxins. Uses in transgenic plants are described as are methods for protecting crops from insect pest damage.

Modified Cry1Ca toxins useful for control of insect pests

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic(Cp) &#x3b1;-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing thesystem, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

[object Object]

Growing community of inventors

Indianapolis, IN, United States of America

Janna Mai Armstrong